Free Trial

Haleon (HLN) Competitors

Haleon logo
GBX 411.50 -2.20 (-0.53%)
As of 12:07 PM Eastern

HLN vs. ULVR, SGE, SN, WHR, ANP, CLX, TPX, PNPL, LEG, and BXP

Should you be buying Haleon stock or one of its competitors? The main competitors of Haleon include Unilever (ULVR), The Sage Group (SGE), Smith & Nephew (SN), Warehouse REIT (WHR), Anpario (ANP), Calnex Solutions (CLX), TPXimpact (TPX), Pineapple Power (PNPL), Legendary Investments (LEG), and Beximco Pharmaceuticals (BXP).

Haleon vs.

Haleon (LON:HLN) and Unilever (LON:ULVR) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, community ranking, media sentiment, analyst recommendations, dividends and profitability.

Haleon currently has a consensus price target of GBX 457, indicating a potential upside of 10.92%. Unilever has a consensus price target of GBX 4,550, indicating a potential downside of 3.05%. Given Haleon's stronger consensus rating and higher possible upside, equities research analysts clearly believe Haleon is more favorable than Unilever.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Haleon
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Unilever
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Haleon pays an annual dividend of GBX 6 per share and has a dividend yield of 1.5%. Unilever pays an annual dividend of GBX 147 per share and has a dividend yield of 3.1%. Haleon pays out 50.5% of its earnings in the form of a dividend. Unilever pays out 66.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Unilever has higher revenue and earnings than Haleon. Unilever is trading at a lower price-to-earnings ratio than Haleon, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Haleon£11.07B3.36£1.07B£11.8934.65
Unilever£70.72B1.96£7.79B£221.0921.23

Haleon has a beta of 0.19, indicating that its stock price is 81% less volatile than the S&P 500. Comparatively, Unilever has a beta of 0.22, indicating that its stock price is 78% less volatile than the S&P 500.

Unilever has a net margin of 11.01% compared to Haleon's net margin of 9.66%. Unilever's return on equity of 34.57% beat Haleon's return on equity.

Company Net Margins Return on Equity Return on Assets
Haleon9.66% 6.54% 4.45%
Unilever 11.01%34.57%8.62%

Unilever received 1002 more outperform votes than Haleon when rated by MarketBeat users. Likewise, 58.18% of users gave Unilever an outperform vote while only 31.58% of users gave Haleon an outperform vote.

CompanyUnderperformOutperform
HaleonOutperform Votes
12
31.58%
Underperform Votes
26
68.42%
UnileverOutperform Votes
1014
58.18%
Underperform Votes
729
41.82%

In the previous week, Haleon had 4 more articles in the media than Unilever. MarketBeat recorded 5 mentions for Haleon and 1 mentions for Unilever. Haleon's average media sentiment score of 1.18 beat Unilever's score of 0.22 indicating that Haleon is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Haleon
2 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Unilever
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

43.9% of Haleon shares are owned by institutional investors. Comparatively, 54.4% of Unilever shares are owned by institutional investors. 10.7% of Haleon shares are owned by company insiders. Comparatively, 0.1% of Unilever shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Unilever beats Haleon on 11 of the 19 factors compared between the two stocks.

Get Haleon News Delivered to You Automatically

Sign up to receive the latest news and ratings for HLN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HLN vs. The Competition

MetricHaleonDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£37.19B£2.17B£5.38B£2.66B
Dividend Yield0.02%2.92%5.21%5.05%
P/E Ratio34.653.9526.76134.07
Price / Sales3.36566.29389.94213,407.41
Price / Cash21.9510.2538.2528.02
Price / Book2.267.126.803.79
Net Income£1.07B£20.70B£3.23B£5.88B
7 Day Performance2.59%-0.39%1.52%0.38%
1 Month Performance6.63%4.87%10.04%21.83%
1 Year Performance24.74%89.84%16.73%120.81%

Haleon Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HLN
Haleon
2.0789 of 5 stars
GBX 411.50
-0.5%
GBX 457
+11.1%
+24.8%£37.14B£11.07B34.6125,408News Coverage
Positive News
Insider Trade
ULVR
Unilever
0.8282 of 5 stars
GBX 4,652
+0.6%
GBX 4,550
-2.2%
+10.3%£137.38B£70.72B21.04148,000
SGE
The Sage Group
1.5686 of 5 stars
GBX 1,229.50
-1.1%
GBX 3,446.67
+180.3%
+15.6%£12.17B£2.14B47.7911,326Earnings Report
Dividend Increase
Buyback Announcement
SN
Smith & Nephew
3.2214 of 5 stars
GBX 1,086
+0.4%
GBX 7,840
+621.9%
+7.9%£11.91B£7.08B39.1018,452High Trading Volume
WHR
Warehouse REIT
1.3281 of 5 stars
GBX 98.20
-0.4%
GBX 108
+10.0%
+18.4%£415.99M£50.81M0.9561,000
ANP
Anpario
1.2341 of 5 stars
GBX 459.25
+1.4%
GBX 435
-5.3%
+80.8%£78.35M£33.50M25.36109Positive News
CLX
Calnex Solutions
2.8652 of 5 stars
GBX 50
-0.7%
GBX 115
+130.0%
+0.6%£44.43M£16.52M1,106.209,000Earnings Report
Analyst Forecast
High Trading Volume
TPX
TPXimpact
N/AGBX 23
-4.2%
N/A-32.0%£20.88M£84.64M-1.0212,000Positive News
PNPL
Pineapple Power
N/AN/AN/AN/A£2.28MN/A-274.002High Trading Volume
LEG
Legendary Investments
N/AN/AN/AN/A£0.00N/A0.0019,900Gap Down
BXP
Beximco Pharmaceuticals
N/AGBX 34.64
-6.3%
N/A-12.5%£23.61B£7.08T3.725,500Gap Down

Related Companies and Tools


This page (LON:HLN) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners